Company patents

Cardio Flow, Inc.

Cardio Flow, Inc. exhibits a highly concentrated patent strategy, with 100.0% of its portfolio in Medical Diagnostics & Surgery, showing robust growth of +30.8% in 2025. While Drug Delivery Devices represents a minor 6.5% of its portfolio, the complete cessation of patenting in this area in 2024 and so far in 2026 suggests a significant shift away from this technology.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

46 US filings (since 2023) · 2 categories · 2 themes

Patents

Showing 1-10 of 57

Page 1 of 6